A pilot study evaluating a novel regimen comprised of carboplatin, paclitaxel, and bevacizumab for advanced-stage ovarian carcinoma. [electronic resource]
Producer: 20110719Description: 1132-6 p. digitalISSN:- 1525-1438
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bevacizumab
- Carboplatin -- administration & dosage
- Carcinoma, Papillary -- drug therapy
- Cystadenocarcinoma, Serous -- drug therapy
- Fallopian Tube Neoplasms -- drug therapy
- Female
- Humans
- Middle Aged
- Neoplasm Staging
- Ovarian Neoplasms -- drug therapy
- Paclitaxel -- administration & dosage
- Peritoneal Neoplasms -- drug therapy
- Pilot Projects
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.